Jennifer Herring

1.3k total citations
21 papers, 788 citations indexed

About

Jennifer Herring is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Jennifer Herring has authored 21 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jennifer Herring's work include Multiple Myeloma Research and Treatments (4 papers), Blood transfusion and management (4 papers) and Protein Degradation and Inhibitors (3 papers). Jennifer Herring is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Blood transfusion and management (4 papers) and Protein Degradation and Inhibitors (3 papers). Jennifer Herring collaborates with scholars based in United States, Sweden and Italy. Jennifer Herring's co-authors include Maureen McMichael, Stephanie A. Smith, Dario Palmieri, Patricia S. Steeg, S. D. Rubin, Eleazar Vega-Valle, Maria J. Merino, Julie L. Bronder, David J. Liewehr and Seth M. Steinberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jennifer Herring

20 papers receiving 767 citations

Peers

Jennifer Herring
Brieuc Sautois Belgium
Elena Del Ferro Italy
Harold C. Sullivan United States
Renate Thalhammer Austria
Adam Corken United States
Alan Le Canada
Soon‐Beom Kang South Korea
C. Bokemeyer Germany
Klara Dalva Türkiye
Nataša Čolović Serbia
Brieuc Sautois Belgium
Jennifer Herring
Citations per year, relative to Jennifer Herring Jennifer Herring (= 1×) peers Brieuc Sautois

Countries citing papers authored by Jennifer Herring

Since Specialization
Citations

This map shows the geographic impact of Jennifer Herring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Herring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Herring more than expected).

Fields of papers citing papers by Jennifer Herring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Herring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Herring. The network helps show where Jennifer Herring may publish in the future.

Co-authorship network of co-authors of Jennifer Herring

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Herring. A scholar is included among the top collaborators of Jennifer Herring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Herring. Jennifer Herring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herring, Jennifer, et al.. (2021). CARES: an innovative approach to treating adolescents with co-occurring mental health and substance use disorders. Children s Health Care. 52(1). 23–44.
2.
Richardson, Paul G., Craig C. Hofmeister, Noopur Raje, et al.. (2017). Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma. Leukemia. 31(12). 2695–2701. 26 indexed citations
3.
Herring, Jennifer. (2016). A novel placement technique for nasogastric and nasoesophageal tubes. Journal of Veterinary Emergency and Critical Care. 26(4). 593–597. 8 indexed citations
4.
Palumbo, Antonio, Philippe Moreau, Meletios Α. Dimopoulos, et al.. (2015). OUTCOMES FOR OLDER PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE STRATUS (MM-010) TRIAL, A SINGLE-ARM, PHASE 3B STUDY. Haematologica. 100. 82–83. 1 indexed citations
5.
Smith, Stephanie A., et al.. (2015). Iron metabolism following intravenous transfusion with stored versus fresh autologous erythrocyte concentrate in healthy dogs. American Journal of Veterinary Research. 76(11). 996–1004. 3 indexed citations
6.
Richardson, Paul G., Craig C. Hofmeister, Noopur Raje, et al.. (2015). A Phase 1, Multicenter Study of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone in Patients with Proteasome Inhibitor Exposed and Lenalidomide-Refractory Myeloma (Trial MM-005). Blood. 126(23). 3036–3036. 11 indexed citations
7.
Herring, Jennifer, et al.. (2014). Mentoring Moms: The critical health and safety needs of pregnant offenders in the Harris County Sherriff’s Office reentry program.. Journal of Family Strengths. 14(1). 1 indexed citations
8.
Smith, Stephanie A., Mauria O'Brien, Jennifer Herring, et al.. (2014). Procoagulant phospholipid concentration in canine erythrocyte concentrates stored with or without prestorage leukoreduction. American Journal of Veterinary Research. 76(1). 35–41. 6 indexed citations
9.
Palumbo, Antonio, Meletios Α. Dimopoulos, Katja Weisel, et al.. (2014). Outcomes for Older Patients in Stratus (MM-010), a Single-Arm, and Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma. Blood. 124(21). 4770–4770. 1 indexed citations
10.
Herring, Jennifer, et al.. (2014). Contrast‐enhanced multidetector computed tomography to diagnose pulmonary thromboembolism in an awake dog with pyothorax. Journal of Veterinary Emergency and Critical Care. 24(6). 731–738. 10 indexed citations
11.
McMichael, Maureen, Stephanie A. Smith, Mauria O'Brien, et al.. (2014). Cytokine concentration in stored canine erythrocyte concentrates. Journal of Veterinary Emergency and Critical Care. 24(3). 259–263. 30 indexed citations
12.
Herring, Jennifer, Maureen McMichael, & Stephanie A. Smith. (2013). Microparticles in Health and Disease. Journal of Veterinary Internal Medicine. 27(5). 1020–1033. 88 indexed citations
13.
Herring, Jennifer, Stephanie A. Smith, Maureen McMichael, et al.. (2013). Microparticles in stored canine RBC concentrates. Veterinary Clinical Pathology. 42(2). 163–169. 37 indexed citations
14.
Herring, Jennifer & Maureen McMichael. (2012). Diagnostic Approach to Small Animal Bleeding Disorders. Topics in companion animal medicine. 27(2). 73–80. 20 indexed citations
15.
McMichael, Maureen, et al.. (2012). RECOVERevidence and knowledge gap analysis on veterinaryCPR. Part 2: Preparedness and prevention. Journal of Veterinary Emergency and Critical Care. 22(s1). S13–25. 16 indexed citations
16.
Rhee, Frits van, Luis Fayad, Peter M. Voorhees, et al.. (2010). Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease. Journal of Clinical Oncology. 28(23). 3701–3708. 177 indexed citations
17.
Gril, Brunilde, Dario Palmieri, Julie L. Bronder, et al.. (2008). Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain. JNCI Journal of the National Cancer Institute. 100(15). 1092–1103. 218 indexed citations
18.
Kurzrock, Razelle, Luis Fayad, Peter M. Voorhees, et al.. (2008). A Phase I Study of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody in Patients with B-Cell Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Castleman’s Disease.. Blood. 112(11). 1009–1009. 4 indexed citations
19.
Rhee, Frits van, Luis Fayad, Peter M. Voorhees, et al.. (2008). CNTO 328, a Monoclonal Antibody to Interleukin-6, Is Active as a Single Agent in Castleman’s Disease: Preliminary Results of a Phase I Study.. Blood. 112(11). 1008–1008. 6 indexed citations
20.
Sink, Ernest L., Lori A. Karol, James O. Sanders, et al.. (2001). Efficacy of perioperative halo-gravity traction in the treatment of severe scoliosis in children.. Journal of Pediatric Orthopaedics. 21(4). 519–524. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brieuc Sautois Breakdown of academic impact, for papers by Elena Del Ferro Breakdown of academic impact, for papers by Harold C. Sullivan Breakdown of academic impact, for papers by Renate Thalhammer Breakdown of academic impact, for papers by Adam Corken Breakdown of academic impact, for papers by Alan Le Breakdown of academic impact, for papers by Soon‐Beom Kang Breakdown of academic impact, for papers by C. Bokemeyer Breakdown of academic impact, for papers by Klara Dalva Breakdown of academic impact, for papers by Nataša Čolović
Rankless by CCL
2026